Effect of Intake of Glycin Max (L.) Merr. Peel Extract on Body Fat and Body Weight

Hanyang University

Status and phase: Completed; Phase 3; Phase 2

Conditions: Obesity

Treatments: Dietary Supplement: Glycin max(L.) Merr. peel extract; Dietary Supplement: Placebo

Study type: Interventional

Funder types: Other

Identifiers

NCT02108691

SSWU-BF-GE

Details and patient eligibility

About

The investigators performed a 8-week, randomized, double-blind, placebo-controlled human trial to evaluate the efficacy and safety of Glycin max (L.) Merr. peel extract on decrement of body fat. The investigators measured decrement of body fat parameters , including Body Fat Mass, Percent Body Fat, weight and BMI(body mass index), and monitored their blood pressure.

Enrollment: 80 patients

Sex: All

Ages: 19 to 65 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Males and females 19-65 years old
• BMI(body mass index) ≥ 25 kg/m^2 or WC(Waist Circumference) ≥ 90(men), WC ≥ 85(women)
• Able to give informed consent

Exclusion criteria

• Significant variation in weight(more 10%) in the past 3 months
• Allergic or hypersensitive to any of the ingredients in the test products
• History of reaction to any of the test products or of gastrointestinal diseases such as Crohn's disease or gastrointestinal surgery
• History of alcohol or substance abuse
• Participation in any other clinical trials within past 2 months
• Laboratory test, medical or psychological conditions deemed by the investigators to interfere with successful participation in the study
• Pregnant or lactating women etc.

Trial design

Primary purpose: Prevention

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind

---

80 participants in 2 patient groups, including a placebo group

Glycin max(L.) Merr. pell extract

Experimental group

Treatment:

Dietary Supplement: Glycin max(L.) Merr. peel extract

Placebo

Placebo Comparator group

Treatment:

Dietary Supplement: Placebo